Treatment of NAFLD With Two Different Diets
TREND
1 other identifier
interventional
74
1 country
1
Brief Summary
The impact of popular diets on liver-related health is unclear. In this randomized, controlled trial, patients with NAFLD will be randomized to one of two popular diets or a placebo diet.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for phase_2
Started Apr 2017
Typical duration for phase_2
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
April 6, 2017
CompletedStudy Start
First participant enrolled
April 6, 2017
CompletedFirst Posted
Study publicly available on registry
April 18, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 31, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
August 31, 2020
CompletedSeptember 2, 2020
August 1, 2020
3.4 years
April 6, 2017
August 31, 2020
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Liver fat
MRI-measured liver fat content
Three months
Study Arms (3)
Placebo
PLACEBO COMPARATORPlacebo diet
5:2
EXPERIMENTAL5:2 diet
LCHF
EXPERIMENTALLCHF diet
Interventions
Eligibility Criteria
You may qualify if:
- Known NAFLD
You may not qualify if:
- Other forms of liver disease
- Bolus insulin treatment
- Cirrhosis
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Center for Digestive Diseases, Karolinska University Hospital
Stockholm, 14186, Sweden
Related Publications (2)
Holmer M, Hagstrom H, Tillander V, Alkadri M, Petersson S, Brismar TB, Stal P, Lindqvist C. One-year follow-up of short-term dietary intervention for MASLD: sustained improvements in steatosis, weight and dietary intake. Scand J Gastroenterol. 2025 Nov;60(11):1087-1095. doi: 10.1080/00365521.2025.2544305. Epub 2025 Aug 12.
PMID: 40797298DERIVEDHolmer M, Lindqvist C, Petersson S, Moshtaghi-Svensson J, Tillander V, Brismar TB, Hagstrom H, Stal P. Treatment of NAFLD with intermittent calorie restriction or low-carb high-fat diet - a randomised controlled trial. JHEP Rep. 2021 Feb 17;3(3):100256. doi: 10.1016/j.jhepr.2021.100256. eCollection 2021 Jun.
PMID: 33898960DERIVED
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Hannes Hagström, MD, PhD
Karolinska University Hospital
Study Design
- Study Type
- interventional
- Phase
- phase 2
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Primary Investigator
Study Record Dates
First Submitted
April 6, 2017
First Posted
April 18, 2017
Study Start
April 6, 2017
Primary Completion
August 31, 2020
Study Completion
August 31, 2020
Last Updated
September 2, 2020
Record last verified: 2020-08
Data Sharing
- IPD Sharing
- Will not share